I am a urologist working in Stockholm and see many patients with bladder pain syndrome/interstitial cystitis. The European Guidelines on Urology recommend the use of Sodiumpentosanpolysulphate, i.e. Elmiron. It is however not available on the Swedish market and when I asked the Swedish Medical Products Agency they explained that your company has not applied for acceptation of Elmiron on our market. Is that so? If so, why not?
Specialist in Urology and Gynecology